| Date | Time | Source | Headline | Symbol | Company |
| 08/09/2010 | 1:37PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/06/2010 | 11:33AM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2010 | 7:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2010 | 3:56PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2010 | 9:00AM | Business Wire | Impax Laboratories Enters Into Development Agreement with Perrigo | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/03/2010 | 10:21AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/03/2010 | 7:00AM | Business Wire | Impax Laboratories Continues Strong Growth in Revenue, Profit and Earnings in the Second Quarter 2010 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/22/2010 | 4:30PM | Business Wire | Impax Laboratories Receives Final FDA Approval for Generic OPANA® ER Tablets | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/13/2010 | 3:35PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/08/2010 | 9:30AM | Business Wire | Impax Laboratories Schedules Conference Call and Webcast for Second Quarter 2010 Financial Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/02/2010 | 3:00PM | Business Wire | Impax Laboratories Confirms Patent Challenge Relating to RENVELA®, 2.4 g and 0.8 g (For Suspension) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/18/2010 | 9:30AM | Business Wire | Impax Laboratories to Present at the Wells Fargo Securities Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/11/2010 | 12:30PM | Business Wire | Impax Laboratories to Present at the Goldman Sachs 31st Annual Global Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/09/2010 | 8:53AM | Marketwired | In the Wait of Patent Expirations | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/08/2010 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/08/2010 | 4:17PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/08/2010 | 4:16PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/08/2010 | 4:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/08/2010 | 10:29AM | Dow Jones News | Penwest Rallies As Impax, Sandoz To Sell Opana ER Generics | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/08/2010 | 9:27AM | PR Newswire (US) | Endo and Penwest Enter Into Agreement with Impax Laboratories to Settle OPANA® ER Patent Litigation | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/08/2010 | 9:15AM | Business Wire | Impax Laboratories & Endo Pharmaceuticals Settle Pending Litigation for Opana® ER & Announce Development & Co-Promotion Agre... | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/07/2010 | 11:00AM | Business Wire | Impax Laboratories to Present at Upcoming Investor Conferences on June 10 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/28/2010 | 2:05PM | Edgar (US Regulatory) | Amended Current report filing (8-K/A) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/28/2010 | 1:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/28/2010 | 1:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/28/2010 | 1:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/28/2010 | 1:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/28/2010 | 1:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/28/2010 | 1:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/28/2010 | 1:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |